John T. Curnutte
2013
In 2013, John T. Curnutte earned a total compensation of $646.7K as Executive Vice President, Research and Development at Portola Pharmaceuticals, a 22% decrease compared to previous year.
Compensation breakdown
| Bonus | $75,000 |
|---|---|
| Non-Equity Incentive Plan | $158,520 |
| Salary | $388,290 |
| Other | $24,859 |
| Total | $646,669 |
Curnutte received $388.3K in salary, accounting for 60% of the total pay in 2013.
Curnutte also received $75K in bonus, $158.5K in non-equity incentive plan and $24.9K in other compensation.
Rankings
In 2013, John T. Curnutte's compensation ranked 8,449th out of 12,286 executives tracked by ExecPay. In other words, Curnutte earned more than 31.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,449 out of 12,286 | 31st |
Division Manufacturing | 3,077 out of 4,612 | 33rd |
Major group Chemicals And Allied Products | 971 out of 1,466 | 34th |
Industry group Drugs | 739 out of 1,160 | 36th |
Industry Pharmaceutical Preparations | 584 out of 890 | 34th |
Source: SEC filing on April 30, 2015.
Curnutte's colleagues
We found two more compensation records of executives who worked with John T. Curnutte at Portola Pharmaceuticals in 2013.